When and how should new therapies become routine clinical practice?
Kari Bø Artikkel Engelsk
*0011574044 *008091027s2009 xx# 000 0 eng *019 $bk *08230$a615.82 *100 $aBø, Kari$uNorges idrettshøgskole, Oslo, Norge : kari.bo@nih.no$_132880500 *245 $aWhen and how should new therapies become routine clinical practice? *300 $aS. 20-24 *500 $aVitenskapelig artikkel *5208 $aInneholder sammendrag *650 $afysioterapi$9nor$2norart$_129558200 *653 $adiffusion of innovation$9eng$_166428500 *653 $ahealthcare reform$9eng$_139652800 *653 $aphysical therapy (specialty)$9eng$_166428600 *653 $arandomised controlled trials as topic$9eng$_166428700 *700 $aHerbert, Robert D.$uThe George Institute for International Health, Camperdown, Australia$_166428800 *773 $tFysioterapeuten$gÅrg. 76, nr. 9 (2009)$x0016-3384$w(NO-LaBS)408622(tnr) *999 $z900458633$anorart:900458633 ^